| 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American college of … TW Rooke, AT Hirsch, S Misra, AN Sidawy, JA Beckman, LK Findeiss, ... Circulation 124 (18), 2020-2045, 2011 | 1296 | 2011 |
| Characterization of fortilin, a novel antiapoptotic protein F Li, D Zhang, K Fujise Journal of Biological Chemistry 276 (50), 47542-47549, 2001 | 353 | 2001 |
| Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and fortilin: the potential role of MCL1 as a fortilin chaperone D Zhang, F Li, D Weidner, ZH Mnjoyan, K Fujise Journal of Biological Chemistry 277 (40), 37430-37438, 2002 | 264 | 2002 |
| Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of “no reflow” phenomenon AR Assali, S Sdringola, M Ghani, AE Denkats, A Yepes, GP Hanna, ... Catheterization and Cardiovascular interventions 51 (1), 27-31, 2000 | 173 | 2000 |
| Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways X Pang, T Yi, Z Yi, SG Cho, W Qu, D Pinkaew, K Fujise, M Liu Cancer research 69 (2), 518-525, 2009 | 161 | 2009 |
| Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry GP Hanna, K Fujise, O Kjellgren, S Feld, C Fife, G Schroth, T Clanton, ... Journal of the American College of Cardiology 30 (3), 664-669, 1997 | 115 | 1997 |
| Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow‐no reflow phenomenon S Sdringola, A Assali, M Ghani, A Yepes, O Rosales, GW Schroth, ... Catheterization and cardiovascular interventions 51 (4), 394-399, 2000 | 94 | 2000 |
| Profound negative regulatory effects by resveratrol on vascular smooth muscle cells: a role of p53–p21WAF1/CIP1 pathway ZH Mnjoyan, K Fujise Biochemical and Biophysical Research Communications 311 (2), 546-552, 2003 | 88 | 2003 |
| Risk assessment of slow or no‐reflow phenomenon in aortocoronary vein graft percutaneous intervention S Sdringola, AR Assali, M Ghani, A Moustapha, H Achour, SW Yusuf, ... Catheterization and cardiovascular interventions 54 (3), 318-324, 2001 | 86 | 2001 |
| Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo P Graidist, M Yazawa, M Tonganunt, A Nakatomi, CCJ Lin, JY Chang, ... Biochemical Journal 408 (2), 181-191, 2007 | 83 | 2007 |
| Human papillomavirus and cardiovascular disease among US women in the National Health and Nutrition Examination Survey, 2003 to 2006 HK Kuo, K Fujise Journal of the American College of Cardiology 58 (19), 2001-2006, 2011 | 80 | 2011 |
| Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no‐reflow phenomenon GP Hanna, P Yhip, K Fujise, GW Schroth, OR Rosales, HV Anderson, ... Catheterization and Cardiovascular Interventions 48 (3), 275-278, 1999 | 77 | 1999 |
| Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity P Graidist, A Phongdara, K Fujise Journal of Biological Chemistry 279 (39), 40868-40875, 2004 | 74 | 2004 |
| Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices AR Assali, S Sdringola, A Moustapha, M Ghani, J Salloum, G Schroth, ... Catheterization and cardiovascular interventions 58 (1), 1-5, 2003 | 67 | 2003 |
| Fortilin binds IRE1α and prevents ER stress from signaling apoptotic cell death D Pinkaew, A Chattopadhyay, MD King, P Chunhacha, Z Liu, ... Nature communications 8 (1), 18, 2017 | 66 | 2017 |
| Human fortilin is a molecular target of dihydroartemisinin T Fujita, K Felix, D Pinkaew, N Hutadilok-Towatana, Z Liu, K Fujise FEBS letters 582 (7), 1055-1060, 2008 | 64 | 2008 |
| Morelloflavone from Garcinia dulcis as a Novel Biflavonoid Inhibitor of HMG‐CoA Reductase K Tuansulong, N Hutadilok‐Towatana, W Mahabusarakam, D Pinkaew, ... Phytotherapy Research 25 (3), 424-428, 2011 | 51 | 2011 |
| Embryonic lethality of fortilin-null mutant mice by BMP-pathway overactivation Y Koide, T Kiyota, M Tonganunt, D Pinkaew, Z Liu, Y Kato, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (5), 326-338, 2009 | 45 | 2009 |
| Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban) AR Assali, J Salloum, S Sdringola, A Moustapha, M Ghani, S Hale, ... American Journal of Cardiology 88 (8), 884-886, 2001 | 43 | 2001 |
| Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration D Pinkaew, SG Cho, DY Hui, JE Wiktorowicz, N Hutadilok-Towatana, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (1), 31-39, 2009 | 42 | 2009 |
